$Outset Medical (OM.US)$ Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors Monday, 6th January at 8:30 am Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt Reports Unaudited Fourth-Quarter Revenue of $29 million and 2024 Revenue of $113 million SAN JOSE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ: OM) ("Outset"), a medical technology co...
$Outset Medical (OM.US)$Revenue for the third quarter of $28.7 million increased 5% compared to $27.4 million in the second quarter and declined 6% from $30.4 million in the third quarter of 2023. Product revenue of $20.3 million rose 6% from $19.2 million in the second quarter and declined 14% from $23.5 million in the third quarter of 2023. Service and other revenue was $8.4 million, roughly even with $8.2 million in the second quarter and an increase of 22% compared to $6.8 milli...
$Outset Medical (OM.US)$MT Newswires· 4 mins ago Outset Medical (OM) said Monday that the US Food and Drug Administration has granted 510(k) clearance for TabloCart with prefiltration, an optional accessory to its Tablo Hemodialysis System dialysis machine. The medical technology company said it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the US.
Report
No comment yet
- No more -
Sign in to post a comment
Trending Stocks
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Outset Medical Stock Forum
Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors
Monday, 6th January at 8:30 am
Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt
Reports Unaudited Fourth-Quarter Revenue of $29 million and 2024 Revenue of $113 million
SAN JOSE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (NASDAQ: OM) ("Outset"), a medical technology co...
📊⚡️📊
Larger Image: tradingview.com...
$Outset Medical (OM.US)$
Outset Medical (OM) said Monday that the US Food and Drug Administration has granted 510(k) clearance for TabloCart with prefiltration, an optional accessory to its Tablo Hemodialysis System dialysis machine.
The medical technology company said it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the US.
No comment yet